A retrospective study to determine rate of renal toxicity in black and white patients with advanced NS-NSCLC treated with platinum-pemetrexed-pembrolizumab
Latest Information Update: 19 Nov 2021
At a glance
- Drugs Pembrolizumab (Primary) ; Pemetrexed (Primary)
- Indications Non-small cell lung cancer
- Focus Adverse reactions; Therapeutic Use
- 19 Nov 2021 New trial record
- 21 Sep 2021 Results presented at the 46th European Society for Medical Oncology Congress